Phospholipase A2: Difference between revisions

Jump to navigation Jump to search
← Older edit
No edit summary
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 15: Line 15:
*'''Pro-phosphlipase (PPLA2)''' is a pancreatic PLA2 whose 7-mer N-terminal peptide is cleaved off to produce the active PLA2.<br />
*'''Pro-phosphlipase (PPLA2)''' is a pancreatic PLA2 whose 7-mer N-terminal peptide is cleaved off to produce the active PLA2.<br />
*For details on Lys49 snake-venom PLA2 see [[Anum-II]].<br />
*For details on Lys49 snake-venom PLA2 see [[Anum-II]].<br />
*For PLA2 inhibitor see [[Atropine]]<br />
*See also [[Phospholipase (Hebrew)]].
*See also [[Phospholipase (Hebrew)]].


Line 29: Line 28:
shows three mail helices in phospholipase A2.  
shows three mail helices in phospholipase A2.  
The <scene name='Diclofenac_binding_to_Phospholipase_A2/Active_site/2'>active site residues</scene> are His 48, Asp 49, Tyr 52 and Glu 99 in the structure.  
The <scene name='Diclofenac_binding_to_Phospholipase_A2/Active_site/2'>active site residues</scene> are His 48, Asp 49, Tyr 52 and Glu 99 in the structure.  
Diclofenac makes several <scene name='Diclofenac_binding_to_Phospholipase_A2/Hydro/1'>Hydrophobic interactions</scene> with the substrate binding site of enzyme. ligand binding is shown in <scene name='Diclofenac_binding_to_Phospholipase_A2/Space_filling/1'>space filling</scene> model of the complex.
Diclofenac makes several <scene name='Diclofenac_binding_to_Phospholipase_A2/Hydro/1'>Hydrophobic interactions</scene> with the substrate binding site of enzyme. ligand binding is shown in <scene name='Diclofenac_binding_to_Phospholipase_A2/Space_filling/1'>space filling</scene> model of the complex. See also [[Diclofenac]].


== Crystal structure of porcine pancreatic phospholipase A<sub>2</sub> in complex with 2-methoxycyclohexa-2-5-diene-1,4-dione ==
== Crystal structure of porcine pancreatic phospholipase A<sub>2</sub> in complex with 2-methoxycyclohexa-2-5-diene-1,4-dione ==
Line 38: Line 37:
<scene name='Journal:FLS:1/Cv/4'>Curcumin</scene> possesses anti-inflammatory activity. The binding of curcumin with PLA<sub>2</sub> was studied using X-ray crystallography. Since the electron density found in the active site did not match with curcumin, <scene name='Journal:FLS:1/Cv/5'>2-methoxycyclohexa-2-5-diene-1,4-dione (MCW)</scene> (the photo-degraded product of curcumin) <scene name='Journal:FLS:1/Cv/6'>was fitted</scene> in the unexplained electron density. To understand the <scene name='Journal:FLS:1/Cv/9'>binding mode of actual curcumin</scene>, molecular docking studies was carried out. <scene name='Journal:FLS:1/Cv/10'>Both crystallographic and docked structures were superimposed</scene>  with respect to the ligand position and identified that <scene name='Journal:FLS:1/Cv/13'>curcumin is binding in the hydrophobic cavity</scene> of PLA<sub>2</sub> with a binding energy -16.81 Kcal/mol. The binding mode is in such a manner that it can prevent the entry of substrate to the hydrophobic active site. These studies indicate that curcumin can be act as an inhibitor to PLA<sub>2</sub>.
<scene name='Journal:FLS:1/Cv/4'>Curcumin</scene> possesses anti-inflammatory activity. The binding of curcumin with PLA<sub>2</sub> was studied using X-ray crystallography. Since the electron density found in the active site did not match with curcumin, <scene name='Journal:FLS:1/Cv/5'>2-methoxycyclohexa-2-5-diene-1,4-dione (MCW)</scene> (the photo-degraded product of curcumin) <scene name='Journal:FLS:1/Cv/6'>was fitted</scene> in the unexplained electron density. To understand the <scene name='Journal:FLS:1/Cv/9'>binding mode of actual curcumin</scene>, molecular docking studies was carried out. <scene name='Journal:FLS:1/Cv/10'>Both crystallographic and docked structures were superimposed</scene>  with respect to the ligand position and identified that <scene name='Journal:FLS:1/Cv/13'>curcumin is binding in the hydrophobic cavity</scene> of PLA<sub>2</sub> with a binding energy -16.81 Kcal/mol. The binding mode is in such a manner that it can prevent the entry of substrate to the hydrophobic active site. These studies indicate that curcumin can be act as an inhibitor to PLA<sub>2</sub>.


== '''Interaction of Atropine with Phospholipase 2A''' ==
== '''Interaction of Atropine with Phospholipase A2''' ==


<scene name='42/420811/Cv/1'>Atropine in complex with phospholipase A2</scene> ([[1th6]]).
<scene name='42/420811/Cv/1'>Atropine in complex with phospholipase A2</scene> ([[1th6]]).
Line 50: Line 49:
The image to the above shows the membrane-bound phospholipase A2 in blue <ref> pla2. http://www.ks.uiuc.edu/Research/smd_imd/pla2/pla2.gif </ref>.
The image to the above shows the membrane-bound phospholipase A2 in blue <ref> pla2. http://www.ks.uiuc.edu/Research/smd_imd/pla2/pla2.gif </ref>.


=== '''Atropine in the Active Site of Phospholipase 2A''' ===
=== '''Atropine in the Active Site of Phospholipase A2''' ===


Atropine is an inhibitor of phospholipase 2A, and can be seen in complex with this enzyme on the left. The <scene name='Sandbox_53/Atropine_structure/1'>structure of atropine</scene> can be seen more clearly in gray using the ball-and stick representation of the drug and protein. It can also be seen in green in this <scene name='Sandbox_53/Phospholipase2a_composition/1'>space-filling model</scene>, where protein appears in brown, ligands appear in green, and solvents appear in blue. Finally, the  
Atropine is an inhibitor of phospholipase 2A, and can be seen in complex with this enzyme on the left. The <scene name='Sandbox_53/Atropine_structure/1'>structure of atropine</scene> can be seen more clearly in gray using the ball-and stick representation of the drug and protein. It can also be seen in green in this <scene name='Sandbox_53/Phospholipase2a_composition/1'>space-filling model</scene>, where protein appears in brown, ligands appear in green, and solvents appear in blue. Finally, the  
Line 59: Line 58:


Removing the labels, atropine can be seen making contact with the atoms emphasized by the space filling model, interacting with the <scene name='Sandbox_53/Phospholipase2a_interactions/1'>active site</scene> of phospholipase 2A through white as-tricks.
Removing the labels, atropine can be seen making contact with the atoms emphasized by the space filling model, interacting with the <scene name='Sandbox_53/Phospholipase2a_interactions/1'>active site</scene> of phospholipase 2A through white as-tricks.
</StructureSection>


== 3D Structures of Phospholipase A2 ==
== 3D Structures of Phospholipase A2 ==
[[Phospholipase A2 3D structures]]


Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
</StructureSection>
{{#tree:id=OrganizedByTopic|openlevels=0|
 
*Phospholipase A2
 
**[[1une]], [[1mkt]], [[1irb]], [[1bp2]], [[1bpq]], [[1g4i]], [[2bp2]], [[2bpp]] - bPLA2 – bovine<br />
**[[2zp3]], [[2zp4]], [[2zp5]], [[1c74]], [[1kvw]], [[1kvx]], [[1kvy]], [[1ceh]], [[1mks]], [[1mku]], [[1vkq]], [[1vl9]], [[2bax]], [[2bch]], [[2bd1]], [[1o3w]], [[1gh4]] – bPLA2 (mutant) – bovine<br />
**[[1bvm]] – bPLA2 - NMR<br />
**[[1qll]], [[2q2j]] – PLA2 – ''Bothrops pirajai''<br />
**[[2qog]] – PLA2 – ''Crotalus durissus''<br />
**[[2ph4]] – PLA2 – ''Zhaoermia mangshanensis''<br />
**[[2h4c]], [[1q6v]] – IvPLA2 – Indian viper<br />
**[[1vpi]] – PLA2 – sand viper<br />
**[[2osn]], [[1fe5]], [[1dpy]] – kPLA2 – krait<br />
**[[1g0z]], [[1g2x]] – kPLA2 (mutant)<br />
**[[2wg7]], [[2wg8]] – rPLA2 – rice<br />
**[[1p2p]], [[4p2p]] – pPLA2 - pig<br />
**[[1y6p]], [[2phi]], [[3p2p]]  – pPLA2 (mutant) – pig<br />
**[[1sfv]], [[1sfw]], [[1pir]], [[1pis]] – pPLA2 - NMR<br />
**[[1yxh]] – NsPLA2 – ''Naja sagittifera''<br />
**[[1oz6]], [[2qhe]] – PLA2 – ''Echis carinatus''<br />
**[[1it4]], [[1it5]] – PLA2 – Stretomyces violaceoruber – NMR<br />
**[[1mg6]] – PLA2 – ''Agkistrodon acutus''<br />
**[[1s8g]], [[1s8h]], [[1s8i]] – PLA2 – copperhead<br />
**[[1ijl]] – PLA2 – ''Deinagkistrodon acutus''<br />
**[[1mc2]], [[4hg9]] – PLA2 – Chinese moccasin<br />
**[[1c74]], [[1kvw]], [[1kvx]], [[1kvy]], [[1ceh]] – bPLA2 (mutant) – bovine<br />
**[[1b4w]], [[1jia]], [[1c1j]] – AhPLA2 - ''Agkistrodon halys''<br />
**[[1a2a]], [[1m8r]], [[1m8s]], [[1psj]] – PLA2 – ''Gloydius halys''<br />
**[[1a3d]], [[1a3f]], [[1ln8]], [[1mh2]], [[1mh8]], [[1ows]], [[1poa]], [[1psh]], [[1s6b]], [[1sz8]], [[1xxw]], [[1y75]], [[1yxl]], [[1yxh]] – PLA2 – ''Naja naja''<br />
**[[1mh7]] - PLA2 – ''Naja sagittifera''<br />
**[[2osh]] – PLA2 – Chinese cobra<br />
**[[1ae7]], [[2not]], [[4e4c]] – PLA2 – ''Notechis scutatus''<br />
**[[1aok]], [[1jlt]], [[1q5t]], [[1rgb]], [[3dih]], [[3g8g]], [[3g8h]] – PLA2 – ''Vipera ammodytes''<br />
**[[2i0u]] – PLA2 – ''Vipera nikolskii''<br />
**[[1ayp]], [[1bbc]], [[1pod]] – hPLA2 – human<br />
**[[1rlw]] – hPLA2 CALB domain<br />
**[[1faz]], [[1kp4]] – PLA2 – ''Streptomyces violaceruber''<br />
**[[1god]] – PLA2 – ''Cerrophidion godmani''<br />
**[[1gp7]], [[1m8t]] – PLA2 – ''Ophiophagus hanna''<br />
**[[1ozy]], [[1p7o]], [[1pwo]] – PLA2 – ''Micropechis ikahena''<br />
**[[1pp2]] – PLA2 – rattlesnake<br />
**[[1ppa]], [[1vap]] – PLA2 – cottonmouth<br />
**[[1u4j]] – PLA2 – ''Bungarus caeruleus''<br />
**[[2aoz]] – PLA2 – ''Atropoides nummifer''<br />
**[[3v9m]] – PLA2 – king brown snake<br />
 
*Phospholipase A2  group I
 
**[[3elo]] – hPLA2G1B<br />
**[[3q4y]] - PLA2G1 - Andaman cobra <br />
**[[3fvi]], [[3fvj]] – pPLA2G1B+octyl sulfate<br />
**[[3qlm]] - pPLA2G1B + hexadecanoic acid<br />
**[[3l30]], [[4dbk]] - pPLA2G1B+berberine derivative<br />
**[[4g5i]] – pPLA2 + DBP<br />
**[[4o1y]] – pPLA2 + naphthalene acetic acid<br />
**[[3osh]] – NnPLA2G1+atropine
 
*Phospholipase A2  group II
 
**[[1j1a]], [[3u8b]] – hPLA2G2A<br />
**[[1n28]], [[1n29]] – hPLA2G2A (mutant)<br />
**[[1cl5]], [[1fb2]], [[1vip]], [[2pvt]], [[2pyc]], [[5vet]] – DrPLA2 – ''Daboia russellii''<br />
**[[2qhw]] – DrPLA2 + gramine derivative<br />
**[[2que]] – DrPLA2 + ajamaline + anisic acid<br />
**[[1kqu]], [[1kvo]] – hPLA2G2A+substrate analog<br />
**[[3u8d]], [[3u8h]], [[3u8i]], [[4hmb]] - hPLA2G2A + inhibitor<br />
**[[5g3n]] - hPLA2G2A (mutant) + inhibitor<br />
**[[5wzw]], [[5wzv]], [[5wzu]], [[5wzt]], [[5wzs]], [[5wzo]], [[5wzm]] - hPLA2G2E + inhibitor<br />
**[[5yse]] - hPLA2G2E (mutant) + inhibitor<br />
**[[3g8f]] – DrPLA2G2+polypeptide<br />
**[[3mlm]] – PLA2G2 + myristic acid – ''Neuwiedi lancehead''<br />
**[[4fga]], [[4gfy]], [[4gld]] – DrPLA2 + polypeptide
 
*Human PLA2 group IVd
**[[5iz5]] – hPLA2GIVd <br />
**[[5ixc]], [[5izr]] – hPLA2GIVd + fluorophosphonate derivative<br />
 
*Phospholipase A2  group V
 
**[[4rfp]] – PLA2 – chinese green tree viper
 
*Human phospholipase A2  group X
 
**[[1le6]], [[1le7]], [[4uy1]], [[5g3m]] – hPLA2G10<br />
**[[5owc]], [[5ow8]] - hPLA2G10 + inhibitor<br />
 
*Human phospholipase A2 group XV
 
**[[4x90]] – hPLA2G15<br />
**[[4x92]] – hPLA2G15 (mutant)<br />
**[[4x91]] – hPLA2G15 + IDFP<br />
**[[4x93]], [[4x94]], [[4x95]], [[4x97]] – hPLA2G15 + arachidonyl derivative<br />
 
*Human phospholipase A2  group XVI
 
**[[2kyt]], [[4dot]], [[4fa0]] – hPLA2G16 N-terminal<br />
 
*Phospholipase A2  group XIII
 
**[[4aup]] – PLA13 – whitish truffle
 
*Phospholipase A2 +inhibitor
 
**[[3o4m]], [[3hsw]] – PLA2+inhibitor <br />
**[[2azy]], [[2azz]], [[2b00]], [[2b01]], [[2b03]], [[2b04]]  – pPLA2+cholate derivative<br />
**[[1y6o]], [[1fx9]], [[1fxf]] – pPLA2+MJ33<br />
**[[1l8s]] – pPLA2+LPC-ether<br />
**[[5p2p]] – pPLA2+substrate analog<br />
**[[3nju]] – PLA2 group I+4-methoxy-benzoic acid – Andaman cobra<br />
**[[2wq5]] – PLA2+minocyclin – Indian cobra<br />
**[[1oxl]] – IcPLA2+indole<br />
**[[3h1x]], [[3fo7]] – IvPLA2+indomethacin <br />
**[[3fg5]] – IvPLA2+pentapeptide+ajmaline<br />
**[[3cbi]] – IvPLA2+anisic acid+ajmaline<br />
**[[2qu9]] – IvPLA2+eugenol<br />
**[[2otf]] – IvPLA2+atenolol<br />
**[[1zwp]] -  IvPLA2+nimesulide<br />
**[[1th6]] -  IvPLA2+atropine<br />
**[[1td7]] -  IvPLA2+niflumic acid<br />
**[[1tgm]] -  IvPLA2+aspirin<br />
**[[2wg9]] – rPLA2+octanoic acid<br />
**[[1oxr]] – NsPLA2+aspirin<br />
**[[1bk9]] – AhPLA2+PBPB<br />
**[[1fdk]] – bPLA2+MJ33<br />
**[[1mkv]] – bPLA2+transition state analog<br />
**[[1o2e]] – bPLA2 (mutant)+anisic acid<br />
**[[2b96]] - bPLA2+benzoic acid derivative<br />
**[[3bp2]] – bPLA2+pyruvic acid<br />
**[[1pob]] - NnPLA2+transition state analog<br />
**[[1poc]] - PLA2+transition state analog – Honey bee<br />
**[[1db4]], [[1db5]], [[1dcy]] – hPLA2+indole<br />
**[[1poe]] – hPLA2+phosphonyl inhibitor<br />
**[[1fv0]] – DrPLA2+aristolochic acid<br />
**[[1sv3]] - DrPLA2+benzoic acid derivative<br />
**[[1tp2]], [[2pws]], [[2q1p]] – DrPLA2+fatty acid<br />
**[[1sv9]], [[1sxk]], [[1zyx]], [[2b17]], [[2qvd]] – DrPLA2+anti-inflammatory agent<br />
**[[1kpm]] – DrPLA2+vitamin E<br />
**[[1oyf]] – DrPLA2+venom-6 methyl-heptanol<br />
**[[1q7a]] – DrPLA2+oxyphenabutazone<br />
**[[1y38]] – DrPLA2+glycerophosphate<br />
**[[1zr8]] – DrPLA2+ajmaline<br />
**[[2arm]] – DrPLA2+atropine<br />
**[[2dpz]] – DrPLA2 +hydroxyphenyl acetamide<br />
**[[2oli]], [[2oth]], [[2oyf]] – DrPLA2+indole derivative<br />
**[[2oub]] – DrPLA2+atenolol<br />
**[[4qem]] – DrPLA2 + coumaric acid<br />
**[[4qer]] – DrPLA2 + resveratrol<br />
**[[4qf7]] – DrPLA2 + corticosterone<br />
**[[4qf8]] – DrPLA2 + spermidine<br />
**[[4qgd]] – DrPLA2 + gramine derivative<br />
**[[4qmc]] – DrPLA2 + biotin derivative<br />
**[[2pmj]] – DrPLA2+benzopyrone<br />
**[[2zbh]] – DrPLA2+bavachalcone<br />
**[[4eix]] - DrPLA2+indomethacin + nimesulide<br />
**[[1po8]], [[1tc8]] – kPLA2+fatty acid<br />
**[[1xxs]] – PLA2+fatty acid – ''Bothrops moojeni''<br />
**[[2qhd]] – EcPLA2+fatty acid<br />
**[[3bjw]] – EcPLA2+suramin<br />
**[[1y4l]] – PLA2+suramin – ''Bothrops asper''
 
*Phospholipase A2 +polypeptide
 
**[[2o1n]], [[2d02]], [[2fnx]], [[1zm6]], [[1tdv]], [[1tg4]], [[1t37]] -  IvPLA2+polypeptide<br />
**[[1jq8]], [[1jq9]] - DsPLA2+polypeptide<br />
**[[1mf4]], [[2rd4]], [[3gci]], [[3jq5]], [[3jql]], [[3jti]] - NnPLA2+polypeptide<br />
**[[1skg]], [[1sqz]], [[1tg1]], [[1tj9]], [[1tjk]], [[1tk4]], [[2do2]], [[2g58]], [[2gns]], [[2pb8]] - DrPLA2+polypeptide
 
*Lp-PLA2
 
**[[1wab]] – bLP-PLA2 + acetate <br />
**[[1bwp]], 1bwq]], 1bwr]], 1es9]] – bLP-PLA2 ( mutant) <br />
**[[1fxw]] – bLP-PLA2 β + γ subunits<br />
**[[1uuj]] - mLP-PLA2 α subunit N terminal – mouse<br />
**[[1vyh]] - mLP-PLA2 α subunit C terminal + β subunit<br />
**[[3d59]] – hLP-PLA2 residues 47-429 <br />
*Lp-PLA2 binary complexes
**[[3dt6]] - bLP-PLA2 α subunit (mutant) + paraoxon<br />
**[[3dt8]] - bLP-PLA2 α subunit (mutant) + sarin<br />
**[[3dt9]] - bLP-PLA2 α subunit (mutant) + soman<br />
**[[3d5e]] - hLP-PLA2 residues 47-429 + paraoxon<br />
**[[3f96]] - hLP-PLA2 residues 47-429 + sarin<br />
**[[3f97]] - hLP-PLA2 residues 47-429 + soman<br />
**[[3f98]] - hLP-PLA2 residues 47-429 + tabun<br />
**[[3f9c]] - hLP-PLA2 residues 47-429 + DFP<br />
**[[5i8p]], [[5i9i]], [[5jad]], [[5jah]], [[5jal]], [[5jan]], [[5jao]], [[5jap]], [[5jar]], [[5jas]], [[5jat]], [[5jau]], [[5lp1]], [[5lz2]], [[5lz8]], [[5lz9]] - hLP-PLA2 residues 47-429 + inhibitor<br />
**[[5lyy]], [[5lz4]], [[5lz5]], [[5lz7]] - hLP-PLA2 residues 47-429 (mutant) + inhibitor<br />
 
*Bothrops toxins
 
**[[3i3h]], [[3i3i]], [[3hzd]], [[2oqd]], [[1zlb]], [[1umv]], [[1u73]], [[1zl7]]  – BTX<br />
**[[3jr8]] – BTXD+Ca<br />
**[[3hzw]], [[3i03]] – BTX+BPB<br />
**[[3iq3]], [[2h8i]] – BTX + PEG<br />
**[[1z76]] – BTX+bromophenacyl<br />
**[[1gmz]], [[1qll]], [[2q2j]], [[2ok9]]  - PTX<br />
**[[3cyl]], [[3cxi]] – PTX+a-tocopherol<br />
**[[2oqd]], [[3jr8]] – BTX-II<br />
 
*Viperotoxin
 
**[[1oqs]] – DrRV4/RV7
 
*cPhospholipase A2
 
**[[1cjy]] - h-cPLA2<br />
**[[1bci]] – h-cPLA2 C2 domain
 
*Pro-Phospholipase A2


**[[1hn4]] – pPPLA2+MJ33<br />
**[[4bp2]] – bPPLA2
}}
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Jaime Prilusky, Joel L. Sussman
Retrieved from "https://proteopedia.openfox.io/w/Phospholipase_A2"